Okicamelliaside targets the N-terminal chaperone pocket of HSP90 disrupts the chaperone protein interaction of HSP90-CDC37 and exerts antitumor activity-Reference-Cited by-同舟云学术

Okicamelliaside targets the N-terminal chaperone pocket of HSP90 disrupts the chaperone protein interaction of HSP90-CDC37 and exerts antitumor activity

Published:2021-07-29 Issue:4 Volume:43 Page:1046-1058
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Cheng Chuan-jing,Liu Kai-xin,Zhang Man,Shen Fu-kui,Ye Li-li,Wu Wen-bo,Hou Xiao-tao,Hao Er-wei,Hou Yuan-yuan,Bai Gang

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41401-021-00737-x.pdf

Reference51 articles.

1. Kim YE, Hipp MS, Bracher A, Hayer-Hartl M, Hartl FU. Molecular chaperone functions in protein folding and proteostasis. Annu Rev Biochem. 2013;82:323–55.

2. Mahalingam D, Swords R, Carew JS, Nawrocki ST, Bhalla K, Giles FJ. Targeting HSP90 for cancer therapy. Br J Cancer. 2009;100:1523–9.

3. Chiosis G, Dickey CA, Johnson JL. A global view of Hsp90 functions. Nat Struct Mol Biol. 2013;20:1–4.

4. Buc Calderon P, Beck R, Glorieux C. Targeting hsp90 family members: a strategy to improve cancer cell death. Biochem Pharmacol. 2019;164:177–87.

5. Huang X, Yan X, Zhang Q, Hong P, Zhang W, Liu Y, et al. Direct targeting of HSP90 with daurisoline destabilizes β-catenin to suppress lung cancer tumorigenesis. Cancer Lett. 2020;489:66–78.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural Optimization of Pyrazole Compounds as Hsp90 Regulators with Enhanced Antitumor Activity;Journal of Medicinal Chemistry;2025-05-01

2. Icaritin Represses Autophagy to Promote Colorectal Cancer Cell Apoptosis and Sensitized Low‐Temperature Photothermal Therapy via Targeting HSP90‐TXNDC9 Interactions;Advanced Science;2025-04-04

3. Advances in the structures, mechanisms and targeting of molecular chaperones;Signal Transduction and Targeted Therapy;2025-03-12

4. Disrupting the Hsp90–Cdc37 axis: a selective strategy for targeting oncogenic kinases in cancer;RSC Advances;2025

5. Chemical proteomics accelerates the target discovery of natural products;Biochemical Pharmacology;2024-12